Lista de obras -

Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy

artículo científico publicado en 2018

Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

artículo científico publicado en 2023

Current and future outlook on disease modification and defining low disease activity in systemic sclerosis

artículo científico publicado en 2020

Current monitoring and treatment of progressive fibrosing interstitial lung disease: a survey of physicians in Japan, the United States, and the European Union

artículo científico publicado en 2020

Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis

scientific article published on 08 December 2019

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

scientific article published on 11 March 2020

Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: results from a multicentre prospective cohort in Japan

scientific article published on 18 June 2020

Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies

scientific article published on 09 April 2018

Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease

artículo científico publicado en 2020

Nintedanib in patients with systemic sclerosis associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial

scientific article published on 03 April 2020

Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease

artículo científico publicado en 2019

Reevaluation of enzyme-linked immunosorbent assay with ultraviolet-treated polystyrene microtiter plates for measurement of antibodies to dsDNA

scientific article published on 01 April 1996

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

artículo científico publicado en 2020

Risk prediction modeling based on a combination of initial serum biomarkers in myositis-associated interstitial lung disease

artículo científico publicado en 2020

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease

artículo científico publicado en 2020

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

artículo científico publicado en 2020

The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method

scientific article published on 26 June 2019

Lista de obras de

Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy

Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

Current and future outlook on disease modification and defining low disease activity in systemic sclerosis

Current monitoring and treatment of progressive fibrosing interstitial lung disease: a survey of physicians in Japan, the United States, and the European Union

Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: results from a multicentre prospective cohort in Japan

Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies

Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease

Nintedanib in patients with systemic sclerosis associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial

Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease

Reevaluation of enzyme-linked immunosorbent assay with ultraviolet-treated polystyrene microtiter plates for measurement of antibodies to dsDNA

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Risk prediction modeling based on a combination of initial serum biomarkers in myositis-associated interstitial lung disease

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method